Nifty

:

24273.80

Sensex

:

80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Login

Nifty
Sensex

:
:

24273.80
80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

2698.75

06-Feb-2025

Open
High
Low
Previous Close

2788.00
2797.30
2682.20
2785.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

90133
2453.41
3485.00
2111.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

31,451.62
34.17
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

31,277.97
N/A
8.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.07
10.22
8.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.78
11.39
4.75

PAT CAGR (%)

10 Years
5 Years
3 Years

10.17
11.78
4.62

P:E (Median)

8 Years
5 Years
3 Years

25.76
27.70
35.12

P:BV (Average)

8 Years
5 Years
3 Years

5.79
6.22
6.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.02
19.52
21.59

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 64.82 76.41 88.37 109.78
P/E Ratio 46.7 39.61 34.25 27.57
Revenue 4162 4692 5267 5864
EBITDA 1172 1343 1550 1894
Net Income 816 962 1116 1386
ROA 17.5 20.4 20.4 19.5
P/B Ratio 10.75 9.53 8.04 6.32
ROE 23.47 25.27 25.39 25.71
FCFF 656.13 814.94 853.33 1339.72
FCFF Yield 1.77 2.2 2.31 3.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,013.94 926.07 9.49% 1,101.92 1,085.29 1.53% 1,128.91 945.18 19.44% 1,077.27 1,014.58 6.18%
Expenses 764.29 698.92 9.35% 765.59 758.11 0.99% 826.00 671.53 23.00% 761.44 737.68 3.22%
EBITDA 249.65 227.15 9.91% 336.33 327.18 2.80% 302.91 273.65 10.69% 315.83 276.90 14.06%
EBIDTM 24.62% 24.53% 30.52% 30.15% 26.83% 28.95% 29.32% 27.29%
Other Income 17.93 33.68 -46.76% 33.23 13.73 142.02% 40.34 52.16 -22.66% 28.37 31.46 -9.82%
Interest 0.67 1.42 -52.82% 2.48 2.36 5.08% 0.73 2.27 -67.84% 0.72 0.75 -4.00%
Depreciation 38.76 33.47 15.81% 34.93 33.41 4.55% 33.32 33.04 0.85% 32.92 32.24 2.11%
PBT 228.15 225.94 0.98% 332.15 305.14 8.85% 309.20 290.50 6.44% 310.56 275.37 12.78%
Tax 34.72 63.25 -45.11% 79.70 84.99 -6.22% 74.22 78.14 -5.02% 74.53 63.33 17.69%
PAT 193.43 162.69 18.89% 252.45 220.15 14.67% 234.98 212.36 10.65% 236.03 212.04 11.31%
PATM 19.08% 17.57% 22.91% 20.28% 20.81% 22.47% 21.91% 20.90%
EPS 15.49 13.03 18.88% 20.21 17.63 14.63% 18.81 17.00 10.65% 18.90 16.98 11.31%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,170.41 1,054.08 11.04% 1,146.13 1,105.15 3.71% 1,186.64 1,028.44 15.38% 1,144.92 1,021.04 12.13%
Expenses 873.26 775.76 12.57% 825.30 791.08 4.33% 875.47 737.78 18.66% 814.57 749.72 8.65%
EBITDA 297.15 278.32 6.77% 320.83 314.07 2.15% 311.17 290.66 7.06% 330.35 271.32 21.76%
EBIDTM 25.39% 26.40% 27.99% 28.42% 26.22% 28.26% 28.85% 26.57%
Other Income 18.11 35.50 -48.99% 30.44 13.59 123.99% 19.48 21.33 -8.67% 26.47 31.75 -16.63%
Interest 6.07 1.53 296.73% 7.91 2.49 217.67% 6.02 2.34 157.26% 0.73 0.85 -14.12%
Depreciation 39.78 34.25 16.15% 35.97 34.26 4.99% 34.39 33.71 2.02% 33.97 33.18 2.38%
PBT 269.41 278.04 -3.10% 307.39 290.91 5.66% 290.24 275.94 5.18% 322.12 269.04 19.73%
Tax 44.15 75.32 -41.38% 74.51 80.88 -7.88% 73.76 80.64 -8.53% 76.35 60.92 25.33%
PAT 225.26 202.72 11.12% 232.88 210.03 10.88% 216.48 195.30 10.84% 245.77 208.12 18.09%
PATM 19.25% 19.23% 20.32% 19.00% 18.24% 18.99% 21.47% 20.38%
EPS 17.97 16.04 12.03% 18.58 16.62 11.79% 17.27 15.46 11.71% 19.61 16.47 19.06%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 1,356.20 Net Sales Growth 8.84% 16.41% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% 14.90% Cost Of Goods Sold 1,012.02 892.98 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 306.55 Gross Profit 3,310.02 3,078.14 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 1,049.65 GP Margin 76.58% 77.51% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% 77.40% Total Expenditure 3,117.32 2,851.69 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 883.64 Power & Fuel Cost - 66.44 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 12.58 % Of Sales - 1.67% 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% 0.93% Employee Cost - 834.16 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 186.34 % Of Sales - 21.01% 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% 13.74% Manufacturing Exp. - 303.25 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 129.58 % Of Sales - 7.64% 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% 9.55% General & Admin Exp. - 362.85 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 46.98 % Of Sales - 9.14% 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% 3.46% Selling & Distn. Exp. - 313.06 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 154.44 % Of Sales - 7.88% 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% 11.39% Miscellaneous Exp. - 78.95 77.39 50.78 61.76 60.43 42.58 88.70 96.63 68.31 154.44 % Of Sales - 1.99% 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% 3.48% EBITDA 1,204.72 1,119.43 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 472.56 EBITDA Margin 27.87% 28.19% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% 34.84% Other Income 119.87 116.48 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 33.70 Interest 4.60 6.80 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 5.01 Depreciation 139.93 132.16 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 49.42 PBT 1,180.06 1,096.95 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 451.83 Tax 263.17 289.71 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 138.51 Tax Rate 22.30% 26.41% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% 31.13% PAT 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 PAT before Minority Interest 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.21% 20.33% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% 22.59% PAT Growth 13.58% 44.48% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% 37.73% EPS 73.41 64.63 44.73 57.63 54.09 35.32 31.37 34.23 40.02 33.78 24.53

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,648.10 4,208.71 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 1,473.56 Net Sales Growth 10.44% 12.45% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% 17.67% Cost Of Goods Sold 1,070.76 880.13 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 290.33 Gross Profit 3,577.34 3,328.58 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 1,183.23 GP Margin 76.96% 79.09% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% 80.30% Total Expenditure 3,388.60 3,036.77 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 968.33 Power & Fuel Cost - 66.57 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 12.91 % Of Sales - 1.58% 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% 0.88% Employee Cost - 900.34 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 200.58 % Of Sales - 21.39% 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% 13.61% Manufacturing Exp. - 303.29 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 130.81 % Of Sales - 7.21% 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% 8.88% General & Admin Exp. - 382.26 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 50.99 % Of Sales - 9.08% 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% 3.46% Selling & Distn. Exp. - 417.54 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 233.96 % Of Sales - 9.92% 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% 15.88% Miscellaneous Exp. - 86.64 88.62 57.27 51.62 64.33 84.19 92.11 104.04 70.90 233.96 % Of Sales - 2.06% 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% 3.31% EBITDA 1,259.50 1,171.94 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 505.23 EBITDA Margin 27.10% 27.85% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% 34.29% Other Income 94.50 84.60 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 16.80 Interest 20.73 7.21 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 5.92 Depreciation 144.11 135.40 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 51.64 PBT 1,189.16 1,113.93 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 464.47 Tax 268.77 297.76 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 146.15 Tax Rate 22.60% 26.73% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% 32.05% PAT 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 PAT before Minority Interest 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.80% 19.39% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% 21.03% PAT Growth 12.77% 38.81% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% 34.13% EPS 73.69 65.35 47.08 57.06 52.35 37.45 30.98 37.52 40.58 33.28 24.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,413.57 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 786.33 Share Capital 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 Total Reserves 3,382.65 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,486.25 1,114.01 768.22 Non-Current Liabilities 174.17 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 54.69 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 22.32 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 9.95 Long Term Provisions 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 4.76 Current Liabilities 629.19 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 244.83 Trade Payables 383.74 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 108.12 Other Current Liabilities 190.39 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 54.51 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 17.90 Short Term Provisions 55.06 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 64.30 Total Liabilities 4,216.93 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 Net Block 1,464.89 1,484.01 1,483.91 1,518.79 1,449.32 1,152.14 1,036.69 572.93 432.83 271.32 Gross Block 2,355.33 2,246.28 2,152.24 2,086.53 1,926.64 1,540.50 1,379.38 859.28 679.21 510.92 Accumulated Depreciation 890.44 762.27 668.33 567.74 477.32 388.36 342.69 286.35 246.38 239.60 Non Current Assets 1,775.77 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 512.82 Capital Work in Progress 256.45 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 170.20 Non Current Investment 37.09 42.99 42.99 17.89 18.63 28.14 18.26 17.26 17.25 57.16 Long Term Loans & Adv. 12.97 134.68 226.15 230.52 163.96 139.91 66.38 34.93 21.12 8.87 Other Non Current Assets 4.37 4.85 5.88 10.65 10.46 12.28 14.18 9.09 4.27 5.27 Current Assets 2,432.82 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 573.03 Current Investments 330.05 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 19.46 Inventories 677.79 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 153.05 Sundry Debtors 1,207.67 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 240.85 Cash & Bank 63.06 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 105.69 Other Current Assets 154.25 18.56 29.78 99.10 229.02 230.92 124.40 55.39 59.94 53.98 Short Term Loans & Adv. 109.91 83.12 81.39 219.81 163.63 137.20 12.71 48.26 53.75 42.01 Net Current Assets 1,803.63 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 328.20 Total Assets 4,208.59 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,567.36 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 841.09 Share Capital 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 Total Reserves 3,536.44 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,550.00 1,173.17 822.98 Non-Current Liabilities 40.82 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 55.67 Secured Loans 0.00 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 23.31 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 9.94 Long Term Provisions 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 4.76 Current Liabilities 895.25 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 249.59 Trade Payables 463.20 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 109.06 Other Current Liabilities 369.52 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 58.33 Short Term Borrowings 0.00 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 17.90 Short Term Provisions 62.53 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 64.30 Total Liabilities 4,503.43 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 Net Block 1,479.19 1,496.44 1,503.58 1,541.11 1,472.14 1,168.35 1,052.66 589.17 450.74 288.09 Gross Block 2,389.41 2,282.82 2,206.86 2,140.80 1,976.15 1,578.96 1,417.23 894.94 715.73 549.85 Accumulated Depreciation 910.22 786.38 703.28 599.69 504.01 410.61 364.57 305.77 264.99 261.76 Non Current Assets 1,773.02 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 512.94 Capital Work in Progress 256.45 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 170.20 Non Current Investment 18.58 25.10 25.10 0.00 12.28 22.87 7.58 0.00 0.00 40.04 Long Term Loans & Adv. 14.43 134.79 236.46 230.74 164.20 148.36 76.79 41.88 21.29 9.34 Other Non Current Assets 4.37 4.85 5.88 11.18 10.46 4.08 4.00 2.34 4.28 5.27 Current Assets 2,722.07 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 633.41 Current Investments 330.05 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 19.46 Inventories 828.36 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 159.03 Sundry Debtors 1,246.84 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 258.76 Cash & Bank 130.77 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 136.76 Other Current Assets 186.05 22.09 34.79 104.15 237.70 240.08 137.73 64.92 66.19 59.40 Short Term Loans & Adv. 132.29 89.39 85.14 223.45 168.68 143.45 23.11 56.29 59.39 47.43 Net Current Assets 1,826.82 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 383.82 Total Assets 4,495.09 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 735.35 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 262.92 PBT 1,096.95 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 444.88 Adjustment 49.31 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 34.18 Changes in Working Capital -158.63 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 -80.75 Cash after chg. in Working capital 987.63 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 398.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.28 -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 -135.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 105.02 -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 -145.63 Net Fixed Assets -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 Net Investments 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 Others 74.93 37.75 52.31 45.45 132.89 116.44 127.90 0.51 75.02 -9.85 Cash from Financing Activity -1,047.70 -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 -101.18 Net Cash Inflow / Outflow -207.33 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 16.11 Opening Cash & Equivalents 268.85 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 7.30 Closing Cash & Equivalent 61.52 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49 23.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 785.07 792.11 561.71 576.31 456.77 374.51 281.12 609.29 326.14 279.42 PBT 1,113.93 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 456.01 Adjustment 83.03 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 51.21 Changes in Working Capital -99.76 66.85 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 -81.69 Cash after chg. in Working capital 1,097.20 943.40 800.84 806.70 611.60 492.74 420.72 760.38 487.63 425.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -312.13 -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 -146.11 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 65.39 -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 -158.36 Net Fixed Assets -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 Net Investments 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 Others 35.30 -20.54 44.25 -74.25 24.40 30.54 72.92 -42.95 5.34 -22.58 Cash from Financing Activity -1,051.06 -108.20 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 -105.19 Net Cash Inflow / Outflow -200.60 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 15.87 Opening Cash & Equivalents 329.83 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 38.62 Closing Cash & Equivalent 129.23 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42 54.49

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 270.68 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 89.35 ROA 18.68% 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% 31.17% ROE 24.26% 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% 46.37% ROCE 33.15% 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% 59.10% Fixed Asset Turnover 1.78 1.59 1.50 1.37 1.27 1.21 1.64 2.37 2.64 2.85 Receivable days 97.40 105.33 104.55 100.41 96.19 88.09 76.59 68.73 68.58 55.76 Inventory Days 60.68 68.73 72.68 70.87 70.66 75.32 49.52 36.95 39.76 40.27 Payable days 150.57 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 47.80 Cash Conversion Cycle 7.51 35.15 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 48.23 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.09 Interest Cover 162.32 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26 89.80

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 282.89 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 95.57 ROA 17.73% 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% 29.57% ROE 23.49% 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% 43.24% ROCE 32.22% 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% 56.43% Fixed Asset Turnover 3.42 3.19 1.56 1.43 1.46 1.37 1.84 2.49 2.76 2.85 Receivable days 52.69 52.87 94.50 93.66 87.08 81.62 67.06 63.41 65.84 56.64 Inventory Days 37.60 40.91 83.71 78.09 65.68 69.82 48.10 37.89 37.93 38.64 Payable days 183.71 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 46.38 Cash Conversion Cycle -93.41 -63.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 48.91 Total Debt/Equity 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 0.09 Interest Cover 155.50 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29 78.03

Top Investors:

uti-flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

kotak small cap fund

canara robeco mutual fund a/c canara robeco emerging equities

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

hdfc large and mid cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ajanta Pharma to expand manufacturing capacity
21st Mar 2025, 14:09 PM

The investments required for the capacity addition is Rs 92 crore
Read More
Ajanta Pharma - Quarterly Results
30th Jan 2025, 15:35 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback